AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2023
Mar 28, 2023
32566_dirs_2023-03-28_8f07cd10-7e37-4e00-8bdb-c7000ff636a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2023-03-27
Reporting Person: Lambert Nicole (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-27 | Common Stock | S | 6433 | $23.48 | Disposed | 240506 | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 9, 2022.
More from MYRIAD GENETICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27